Form 4: Vigil Neuroscience Chief Science Officer Acquires Stock Options
SEC Form 4 Filing
David L.F. Gray, Chief Science Officer of Vigil Neuroscience, Inc., reports the acquisition of stock options.
Summary
- David L.F. Gray, the Chief Science Officer of Vigil Neuroscience, Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of stock options on March 3, 2025.
- Gray acquired options to purchase 125,000 shares of common stock at an exercise price of $2.19.
- The options vest in 48 equal monthly installments starting on April 3, 2025, and expire on March 3, 2035.
Sentiment
Score: 6
Explanation: The document is a standard SEC filing related to stock option grants, which is generally neutral. The grant to the CSO could be seen as a slightly positive sign of confidence.
Positives
- The acquisition of stock options by a key executive could signal confidence in the company's future prospects.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the stock option award transaction. |
| 04/03/2025 | First vesting date of the stock options. |
| 03/03/2035 | Expiration date of the stock options. |
| 03/04/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.